Gold vs US Dollar

Register for streaming realtime charts, analysis tools, and prices.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Celldex Therapeutics Inc (CLDX)
Celldex Therapeutics Inc (CLDX) Financials

CLDX Celldex Therapeutics Inc

24.49

-0.77 (-3.05%)

01 Feb 2025 - Closed

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-35.656	-26.619	-64.138	-36.505	-33.325	-20.724	-28.173	-34.564
Return on Equity (%)	-46.272	-37.079	-83.891	-46.659	-39.409	-22.426	-30.127	-37.446
Return on Invested Capital (%)	-49.488	-38.364	-25.673	-49.262	-29.107	-20.498	-29.934	-40.913
Operating Margin (%)	-1894.047	-920.607	-1593.091	-1423.957	-821.61	-1520.92	-4765.592	-2054.758
Net Profit Margin (%)	-1894.047	-730.056	-1585.07	-1423.957	-805.878	-1516.04	-4765.592	-2054.758
Book Value Per Share	0.771	0.562	6.303	2.671	4.511	8.395	6.335	8.505
Earnings Per Share	-1.066	-0.672	-12.643	-2.998	-1.509	-1.509	-2.38	-2.992
Cash Per Share	0.352	0.291	2.033	0.662	1.107	0.838	0.623	0.737
Working Capital Per Share	1.33	0.845	7.232	3.244	4.637	8.438	6.336	8.475
Operating Profit Per Share	0.056	0.098	3.275	0.287	0.294	0.13	0.195	0.146
EBIT Per Share	-1.066	-0.847	-12.707	-2.998	-1.539	-1.514	-2.38	-2.992
EBITDA Per Share	-1.066	-0.847	-12.707	-2.998	-1.539	-1.514	-2.38	-2.992
Free Cash Flow Per Share	-1.078	-0.697	-12.893	-3.114	-1.521	-1.548	-2.402	-3.017

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	120.52M	138.52M	11.96M	16.97M	39.6M	46.73M	47.2M	N/A

Key Stats and Ratios

Year End 31 December 2023	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	47.2M	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	-3036.298	N/A	N/A	N/A	-21030.769	N/A	N/A
Net Profit Margin (%)	N/A	-3036.298	N/A	N/A	N/A	-21030.769	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	1.68B
Price to Earnings Ratio	-11.49
Price to Sales Ratio	236.26
Price to Cash Ratio	46.69
Price to Book Ratio	3.79
Dividend Yield	-

Share Statistics

Shares Outstanding	66.34M
Average Volume (1 week)	785.68k
Average Volume (1 Month)	1.11M
52 Week Change	-32.01%
52 Week High	53.18
52 Week Low	22.165

More Ratios Coming Soon!

Celldex Therapeutics

INTESA SANPAOLO

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions